Merck Hit With Antitrust Suit Over Vaccine Bundle Discounts

By Kat Greene (April 26, 2018, 8:36 PM EDT) -- A pediatric medical practice accused Merck & Co. of locking down the market for the rotavirus vaccine by "bundling" the drug with other childhood vaccines it sells to practitioners at a discount, according to a proposed class action in Pennsylvania federal court Wednesday.

Merck allegedly gives customers for pediatric vaccines a discount if they agree to buy a suite of childhood vaccines from the company, creating a situation in which customers are loathe to buy Merck's only rotavirus competitor, made by GlaxoSmithKline PLC, because it would mean paying higher prices not only for that drug but for all the other vaccines...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!